Moxonidine Hydrochloride is a selective agonist at the imidazoline receptor subtype 1, used as antihypertensive agent.Target: I1-RMoxonidine Hydrochloride is a centrally acting antihypertensive agent. Mixed Nischarin (I1 imidazoline receptor) and α2-AR (adrenergic) agonist; displays 40-fold higher affinity for I1 receptors versus α2-adrenoceptors. Moxonidine reduced stimulated NE overflow (log EC50: -6.15 +/- 0.14). AGN192403, a selective ligand at I1-R, had no influence on the dose-response curve of moxonidine (log EC50: -6.01 +/- 0.25) . The hypotensive and bradycardic actions of moxonidine but not clonidine are mediated through imidazoline receptors and are dependent on intact noradrenergic pathways within the RVLM. Furthermore, the noradrenergic innervation may be associated with a 42 kDa imidazoline receptor protein .
Moxonidine Hydrochloride is a selective agonist at the imidazoline receptor subtype 1, used as antihypertensive agent.Target: I1-RMoxonidine Hydrochloride is a centrally acting antihypertensive agent. Mixed Nischarin (I1 imidazoline receptor) and α2-AR (adrenergic) agonist; displays 40-fold higher affinity for I1 receptors versus α2-adrenoceptors. Moxonidine reduced stimulated NE overflow (log EC50: -6.15 +/- 0.14). AGN192403, a selective ligand at I1-R, had no influence on the dose-response curve of moxonidine (log EC50: -6.01 +/- 0.25) . The hypotensive and bradycardic actions of moxonidine but not clonidine are mediated through imidazoline receptors and are dependent on intact noradrenergic pathways within the RVLM. Furthermore, the noradrenergic innervation may be associated with a 42 kDa imidazoline receptor protein .
体外研究
Moxonidine (10 μM; 48 h) hydrochloride can prevent mild decrease in myocardial cell viability/mitochondrial activity induced by IL-1 β and TNF - α.
Moxonidine (10 μM; 2 h) hydrochloride increases the uptake of oxidized low-density lipoprotein by vascular smooth muscle cells through α 2-adrenergic receptors.
Moxonidine (30 μM) hydrochloride inhibits voltage dependent N-type Ca2+currents by activating the imidazoline I1 receptor in rat cervical ganglion neurons.
体内研究
Moxonidine (18 mg/kg/day; Oral administration; Through drinking water) hydrochloride can reduce the formation of atherosclerosis in the aortic arch and left common carotid artery of ApoE -/- mice infused with Angiotensin II, and is accompanied by an increase in plasma lipid hydroperoxide level .
Moxinidine (100-1000 μg/kg; intravenous injection) and hydrochloride caused dose-dependent hypotension and bradycardia in awake wild-type mice.
Moxonidine (3-6 mg/kg/day; Implanting permeable micro pumps subcutaneously; 21 days) Hydrochloride inhibits sympathetic nervous activation caused by myocardial infarction in a dose-dependent manner, and high doses can restore normal ventricular weight to body weight ratio and interstitial collagen in myocardial infarction rats.
Moxinidine (20-80 nmol; intraventricular injection into the fourth ventricle) hydrochloride dose dependently reduces mean arterial pressure, heart rate, and sympathetic nerve output in conscious spontaneously hypertensive rats, with a stronger effect than injection into the lateral ventricle.
分子式
C9H13Cl2N5O
分子量
278.14
CAS号
75536-04-8
中文名称
盐酸莫索尼定
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
2-8°C, sealed storage, away from moisture and light
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
溶解性数据
In Vitro:
DMSO : 100 mg/mL (359.53 mM; Need ultrasonic)
H2O : ≥ 100 mg/mL (359.53 mM)
* "≥" means soluble, but saturation unknown.
配制储备液
浓度溶剂体积质量
1 mg
5 mg
10 mg
1 mM
3.5953 mL
17.9766 mL
35.9531 mL
5 mM
0.7191 mL
3.5953 mL
7.1906 mL
10 mM
0.3595 mL
1.7977 mL
3.5953 mL
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。
In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂: